---
layout: entry
title: "SnapShot: COVID-19"
link: "https://doi.org/10.1016/j.cell.2020.04.013"
author:
- Oberfeld, Blake; Achanta, Aditya; Carpenter, Kendall; Chen, Pamela; Gilette, Nicole M.; Langat, Pinky; Said, Jordan Taylor; Schiff, Abigail E.; Zhou, Allen S.; Barczak, Amy K.; Pillai, Shiv

summary:
- "Viral entry is mediated through viral spike protein and host ACE2 enzyme interaction. Most cases are mild; severe disease often involves cytokine storm and organ failure. Therapeutics including antivirals, immunomodulators, and vaccines are in development. To view this SnapShot, open or download the PDF. The PDF is available in PDF format. Vaccines, vaccines and antiviral drugs are in developing."

original:
- "Coronavirus disease 2019 (COVID-19) is a novel respiratory illness caused by SARS-CoV-2. Viral entry is mediated through viral spike protein and host ACE2 enzyme interaction. Most cases are mild; severe disease often involves cytokine storm and organ failure. Therapeutics including antivirals, immunomodulators, and vaccines are in development. To view this SnapShot, open or download the PDF."
---

